Wall Street analysts call the CMS TAVR proposal a "clear positive" for the sector, with Edwards Lifesciences, Medtronic, and ...
For 14 years, patient access to TAVR has been restricted for Medicare beneficiaries under a Coverage with Evidence Development requirement. This could change by June 15.
NEW YORK, NY—A systematic program designed to close the diagnosis and treatment gaps for patients with aortic stenosis (AS) ...
MedPage Today on MSN
Midterm TAVR data turn muddy: Will 10 years even suffice for a verdict?
Real-world mortality complicates reassurances in trial results ...
MedPage Today on MSN
Rabbit fever alert; med school faces bias claim; TAVR program still under fire
Health news and commentary gathered by MedPage Today staff ...
CMS released a proposed decision memo June 15 that would substantially reshape Medicare coverage for transcatheter aortic valve replacement, and the nation’s leading cardiology and cardiothoracic ...
MedPage Today on MSN
Balloon-Expandable TAVR Has Struggles Evident at 10-Year Follow-Up
Mortality linked to second-generation Sapien XT in intermediate surgical risk cohort ...
Since 2022, Benefis Health System, the major nonprofit hospital in Great Falls, has sought to bring a specialty heart procedure to the vast region it serves in central Montana. The ...
Inc., a healthcare AI company focused on helping clinicians identify and manage patients with untreated heart disease, today announced the expansion of its Medical Advisory Board (MAB). Joining the ...
AccurKardia, an innovator in ECG-based diagnostics technology, today announced that its AK-AVS™ aortic valve stenosis (AVS) screening software has been accepted into the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results